Poster: CLL-035 Long-term Survival After Fludarabine, Cyclophosphamide, and Rituximab Treatment in Previously Untreated Chronic Lymphocytic Leukemia Patients

Autor:	Mustafa, Shokhan Mohammad 1, Yassin, Ahmed Khudair 2, Mohammed, Nawsherwan S. 2, Shamoon, Rawand P. 2, Karma, Marwa N. 1, Mohammad, Shlan S. 1, Abdulrahman, Lara Lateef 1, Ahmed, Zhalla O. 1, Rashid, Bryar Sabah 1, Mahmood, Tavan I. 1, Yousif, Rozhhat A. 1, Hasan, Kawa M. 2, Mohamed, Zaki A. 2, Getta, Hisham A. 1, Jalal, Sana D. 2, Abdullah, Dana A. 2, Abdulla, Basil K. 1, Numan, Ghanim S. 1, Karadagh, Ranan 2
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S141-S141
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect